» Articles » PMID: 31091750

The Effect of Aspirin on Preventing Vascular Access Dysfunction in Incident Hemodialysis Patients: A Prospective Cohort Study in Korean Clinical Research Centers for End-Stage Renal Disease (CRC for ESRD)

Overview
Journal J Clin Med
Specialty General Medicine
Date 2019 May 17
PMID 31091750
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Aspirin is often prescribed empirically to improve the patency of hemodialysis (HD) vascular access. Therefore, this study aimed to investigate the impact of aspirin on the survival of vascular access in incident HD patients with arteriovenous fistula (AVF) or arteriovenous graft (AVG). A prospective cohort of 881 incident HD patients was enrolled between 2009 and 2014. The primary outcome was defined as the first AVF/AVG intervention or salvage procedure, including percutaneous transluminal angioplasty or surgery for vascular access failure. Cox analyses were performed to determine the association between aspirin usage and the occurrence of the primary outcome. The mean age of the patient group was 57.9 ± 13.4, and 63.8% of the patients were male. Aspirin was prescribed in 241 (27.4%) patients, and the median follow-up duration was 30 months. During follow-up, 180 (20.4%) patients experienced the primary outcome event. Univariate analysis showed that age, gender, presence of diabetes mellitus (DM), preexisting peripheral arterial disease, and the type of vascular access used (AVG versus AVF) were significantly associated with the development of the primary outcome. However, aspirin usage from the baseline was not significantly associated with primary outcome events (hazard ratio (HR): 1.16; 95% confidence interval (CI): 0.84-1.60; = 0.378). Multivariate analysis showed that gender, the presence of DM, and the type of vascular access were still significantly associated with the occurrence of the primary outcome. Moreover, we did not observe the protective effect of taking aspirin on primary vascular access failure, even in subgroup analyses stratified according to gender, the presence of DM, and the type of vascular access. Physicians should carefully consider when they prescribe aspirin for the prevention of primary vascular access failure in Korean incident HD patients. In addition, larger prospective interventional studies are needed to elucidate the effect of aspirin on vascular access failure.

Citing Articles

Advances in Understanding Lipopolysaccharide-Mediated Hepatitis: Mechanisms and Pathological Features.

Nakadate K, Saitoh H, Sakaguchi M, Miruno F, Muramatsu N, Ito N Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996800 PMC: 11854089. DOI: 10.3390/cimb47020079.


Uncommon Surgical Management by AVF between the Great Saphenous Vein and Anterior Tibial Artery for Old Radiocephalic AVF Failure.

Kaller R, Muresan A, Arbanasi E, Arbanasi E, Kovacs I, Horvath E Life (Basel). 2022; 12(4).

PMID: 35455020 PMC: 9025436. DOI: 10.3390/life12040529.


Expert consensus on the establishment and maintenance of native arteriovenous fistula.

Zhang H, Lu H, Li W, Jiang G, Zou H Chronic Dis Transl Med. 2021; 7(4):235-253.

PMID: 34786543 PMC: 8579016. DOI: 10.1016/j.cdtm.2021.05.002.


Chronic Kidney Disease: The Silent Epidemy.

Bellasi A, Di Lullo L, Di Iorio B J Clin Med. 2019; 8(11).

PMID: 31717778 PMC: 6912263. DOI: 10.3390/jcm8111795.

References
1.
. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002; 324(7329):71-86. PMC: 64503. DOI: 10.1136/bmj.324.7329.71. View

2.
Grosser N, Schroder H . Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway. Arterioscler Thromb Vasc Biol. 2003; 23(8):1345-51. DOI: 10.1161/01.ATV.0000083296.57581.AE. View

3.
Tonelli M, Klarenbach S, Jindal K, Manns B . Economic implications of screening strategies in arteriovenous fistulae. Kidney Int. 2006; 69(12):2219-26. DOI: 10.1038/sj.ki.5000151. View

4.
Yevzlin A, Conley E, Sanchez R, Young H, Becker B . Vascular access outcomes and medication use: a USRDS study. Semin Dial. 2006; 19(6):535-9. DOI: 10.1111/j.1525-139X.2006.00218.x. View

5.
Ethier J, Bragg-Gresham J, Piera L, Akizawa T, Asano Y, Mason N . Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2007; 50(4):602-11. DOI: 10.1053/j.ajkd.2007.07.007. View